Estimate Recalculated Nov 7, 2024 04:44PM EST
Raymond Debbane does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include WW INTERNATIONAL, INC., eHealth, Inc., LEXICON PHARMACEUTICALS, INC., ANTIGENICS INC /DE/, Blue Buffalo Pet Products, Inc., Ceres, Inc., NITROMED INC, and GLYCOMIMETICS INC.
Raymond Debbane's CIK is 0001053890
2019 was Raymond Debbane's most active year for acquiring shares with 58 total transactions. Raymond Debbane's most active month to acquire stocks was the month of August. 2018 was Raymond Debbane's most active year for disposing of shares, totalling 3 transactions. Raymond Debbane's most active month to dispose stocks was the month of March. 2016 saw Raymond Debbane paying a total of $1,000,168.31 for 94,580 shares, this is the most they've acquired in one year. In 2018 Raymond Debbane cashed out on 93,694 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!